Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial-Reference-Cited by-同舟云学术

Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial

Published:2017-03-01 Issue:3 Volume:12 Page:e0172735
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Saglimbene Valeria,Palmer Suetonia C.^ORCID,Craig Jonathan C.,Ruospo Marinella,Nicolucci Antonio,Tonelli Marcello,Johnson David,Lucisano Giuseppe,Williams Gabrielle,Valentini Miriam,D’Alonzo Daniela,Pellegrini Fabio,Strippoli Paolo,Salomone Mario,Santoro Antonio,Maffei Stefano,Hegbrant Jörgen,Tognoni Gianni,Strippoli Giovanni F. M.^ORCID,

Funder

Agenzia Italiana del Farmaco, Ministero della Salute

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis;CG Winearls;Lancet,1986

2. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group;BMJ,1990

3. Morbidity and mortality in hemodialysis patients with and without erythropoietin treatment: a controlled study;J Bahlmann;Contrib Nephrol,1991

4. Erythropoietin treatment in anaemic patients on haemodialysis;B Zins;Lancet,1986

5. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS);F Locatelli;Nephrol Dial Transplant,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the safety of Roxadustat for cardiovascular events in chronic kidney disease-related anemia using meta-analysis and bioinformatics;Frontiers in Pharmacology;2024-06-19

2. The Use of Anemia Control Model Is Associated with Improved Hemoglobin Target Achievement, Lower Rates of Inappropriate Erythropoietin Stimulating Agents, and Severe Anemia among Dialysis Patients;Blood Purification;2024

3. Erythropoiesis-stimulating agents and cardiovascular mortality: A systematic review and meta-analysis of 17 studies and 372,156 hemodialysis patients;International Journal of Cardiology Cardiovascular Risk and Prevention;2023-12

4. Investigating the relationship between erythropoiesis-stimulating agents and mortality in hemodialysis patients: A systematic review and meta-analysis;PLOS ONE;2023-11-09

5. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-02-13